AOD-9604.
Growth-hormone fragment that targets fat metabolism without affecting blood sugar.
What AOD-9604 does.
Clinical effects most commonly reported. Individual response varies — your physician sets the appropriate cycle and dose.
- Stimulates lipolysis (fat breakdown) and inhibits lipogenesis
- Derived from the fat-reducing region of growth hormone
- Does not impact blood glucose or IGF-1 levels
- Subcutaneous injection
AOD-9604 is a modified fragment of growth hormone — the last 16 amino acids of the molecule, the region tied to fat metabolism — studied for body-composition support without the systemic effects of full HGH.
Get AOD-9604.
Start an inquiry, or send a question first.
Prescription products require a consultation with a licensed clinician through our independent clinical partner. Compounded medications are not FDA-approved, and statements about them have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. Results may vary. Consult your physician before starting any protocol. Certain materials on this website, including text, images, and other media, may be generated or enhanced using artificial intelligence technologies.